中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 6
Jun.  2003
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2003  >  19(6): 364-365

缬沙坦对慢性肝病患者肾素-血管紧张素系统的调控及临床意义

  • Published Date: 2003-06-20
    Abstract
  • To study the effect of valsartan on renin-angiotensin system (RAS) of chronic hepatitis and liver cirrhosis 54chronic hepatitis and liver cirrhosis patients were randomly divided into two groups: therapy group and control group. 27 cases in each group. The control group was treated with routine treatment, the therapy group, besides routine treatment, was added valsartan 80mg/day. The therapy period is 1 month. Before and after treatment, serum renin (PRA) ?angiotensin Ⅱ (AⅡ) ?aldosterone (ALD) were measured by radioimmunoassay. In therapy group, before and after therapy, 5 cases of chronic hepatitis patients' liver tissue were obtained by liver biopsy, then semi-quantity RT-PCR method was used to measure the expression of liver tissue angiotensinogen mRNA?angiotensin Ⅱ type Ⅰ receptor mRNA. As a result, in therapy group, after treated with valsartan, the PRA?AⅡ were elevated remarkably (P<0.05) , ALD was lower (P<0.05) ?In therapy group, the patients' PRA?AⅡ were all elevate significantly (P<0.01) , the ALD was decreased (P<0.001) ;after treated by valsartan, the expression of liver tissue angiotensinogen mRNA?angiotensin Ⅱ type Ⅰ receptor mRNA were all lower than before (P<0.05) . So valsartan can modulate the patients' circulation and local liver tissue renin-angiotensin system, thus inhibit the overactive of the renin-angiotensin-aldosterone system in patients with chronic hepatitis and liver cirrhosis.

     

    • FullText(HTML)
    • References(7)
  • [1] 病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 6∶324-329.
    [2]MartinPaul, JurgenWagner, VictorJ , etal.Geneexpressionoftherenin-angiotensinsysteminhumantissues:quantitativeanalysisbythepolymerasechainreaction[J].JClinInvest, 1993, 91∶2058-2064.
    [3]TerryMorgan, CatherineCraven, LennethWard, etal.Humanspiralarteryreninangiotensinsystem[J].Hypertation, 1998, 32∶683-687.
    [4]Goodfriendt, EliottM , CattK .etal.AngiotensinⅡreceptorandtheirantagonist[J].NEnglJMed, 1996, 334∶1649-1654.
    [5]HiroshiIwao, AkioNakamara, KiyoshiFuhui, etal.Endogenousan giotensinⅡregulateshepaticangiotensinogenproduction[J].Lifesci ence, 1990, 47∶2343-2349.
    [6] 卢建, 余应年, 徐仁宝.受体信号转导系统与疾病[M].济南:山东科学技术出版社, 2001.628-630.
    [7]张晶, 魏红山, 李定国.血管紧张素Ⅱ与肝硬化[J].中华消化杂志, 2002, 22 (6) ∶363-365.
    • Relative Articles

  • Relative Articles

    [1]Li Shuang, Tao YanYan, Xing Feng, Zhao Qiang, Liu ChengHai. Effect of Xiaozhang plaster in treatment of cirrhotic ascites and its influence on the renin-angiotensin-aldosterone system[J]. Journal of Clinical Hepatology, 2019, 35(7): 1496-1500. doi: 10.3969/j.issn.1001-5256.2019.07.015
    [2]Liu XiaoYa, Liu RuiXia, Yin ChengHong. Expression and significance of classical ACE-AngII-AT1 axis and new ACE2-Ang (1-7)-Mas axis of renin-angiotensin system in local pancreas[J]. Journal of Clinical Hepatology, 2015, 31(9): 1554-1557. doi: 10.3969/j.issn.1001-5256.2015.09.049
    [3]Liu JianJun, Li Nan, Zhi Hong, Wu XiaoYing. Current clinical perspectives and implications of cirrhotic ascites in China[J]. Journal of Clinical Hepatology, 2012, 28(9): 701-703.
    [4]Duan ZhiJun, Zheng MiaoLei, Li YuLing, Cui DongSheng. Mechanism, prevention and treatment of osteoporosis in chronic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(8): 633-636+640.
    [5]Li QiuLian, Gao Ge, Wang LiQun. Relationship between serum ferritin and the indexes of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2007, 23(3): 179-180.
    [7]Shen FengJun, Yin ChengHong, Zhu YueKe, Jia JiDong, Wang BaoEn. MMP2 gene expression and the effect of angiotensin II type l receptor blocker valsartan on DMN hepatic fibrosis model[J]. Journal of Clinical Hepatology, 2005, 21(1): 19-20.
    [8]Zhang DaiMin, Xu HuiBin, Zhang Ying. Significance of serum GPDA for diagnosis of chronic liver diseases[J]. Journal of Clinical Hepatology, 2004, 20(6): 331-332.
    [12]Li Juan, Guo YanBin, Niu AiQiu, Song YanHua, Sun GuiZhen. The clinical and drug sensitivity test analysis in 40 chronic hepatopathy patients with SBP[J]. Journal of Clinical Hepatology, 2002, 18(5): 302-304.
    • Supplements(0)
    • Cited By
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04051015
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 5.4 %FULLTEXT: 5.4 %META: 91.0 %META: 91.0 %PDF: 3.7 %PDF: 3.7 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 1.7 %其他: 1.7 %[]: 0.3 %[]: 0.3 %上海: 3.7 %上海: 3.7 %北京: 11.4 %北京: 11.4 %南宁: 0.3 %南宁: 0.3 %台州: 0.7 %台州: 0.7 %吉林: 0.7 %吉林: 0.7 %哥伦布: 0.3 %哥伦布: 0.3 %娄底: 0.3 %娄底: 0.3 %张家口: 6.7 %张家口: 6.7 %新加坡: 0.3 %新加坡: 0.3 %昆明: 0.3 %昆明: 0.3 %杭州: 1.0 %杭州: 1.0 %武汉: 0.3 %武汉: 0.3 %深圳: 0.7 %深圳: 0.7 %烟台: 0.3 %烟台: 0.3 %石家庄: 0.7 %石家庄: 0.7 %舟山: 0.3 %舟山: 0.3 %芒廷维尤: 30.4 %芒廷维尤: 30.4 %苏州: 0.3 %苏州: 0.3 %衢州: 0.7 %衢州: 0.7 %西宁: 35.5 %西宁: 35.5 %西安: 0.3 %西安: 0.3 %金华: 0.3 %金华: 0.3 %长春: 2.3 %长春: 2.3 %其他[]上海北京南宁台州吉林哥伦布娄底张家口新加坡昆明杭州武汉深圳烟台石家庄舟山芒廷维尤苏州衢州西宁西安金华长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2224) PDF downloads(22) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[1683]YesterdayPV[2913]TodayIP[2250]TodayPV[5249]Online[62]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return